Abstract:Some recent clinical reports have shown that the combination of oxymatrine, a phyto-derived drug, with lamivudine (3TC) could improve its curative effect against hepatitis B virus (HBV) infection. However, the experimental data in support of this combination strategy are lacking. In this study, we investigated the anti-HBV activity of the combination of 3TC and either oxymatrine or matrine on HepG2 2.2.15 in vitro. The activities of the combination and the solo compound, each in different concentrations, were compared on the 3rd, 6th, and 9th experimental days. The cytotoxicity results showed that the nontoxic concentrations of both oxymatrine and matrine to HepG2 2.2.15 cells were 800 μg/mL. We found that the single use of oxymatrine below 100 μg/ml, matrine below 200 μg/ml, and 3TC below 30 μg/ml showed weak inhibitory effects on the secretion of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and HBV-DNA in culture media; the combination of 3TC (30 μg/ml) with oxymatrine (100 μg/ml) or matrine (100 μg/ml) showed significant inhibitory effects that were higher than or equivalent to the single use of 3TC at 100 μg/ml. The results provide a new impetus to develop novel, multicomponent anti-HBV drugs through the combination of natural products with nucleoside analogs to enhance their activity.

Synthesis and anti-hepatitis B virus activities of Matijin-Su derivatives

Synthesis and Biological Evaluation of Matijin‐Su Derivatives As Potential Antihepatitis B Virus and Anticancer Agents

Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.

Synthesis of Janus Type Nucleoside Analogues and Their Preliminary Bioactivity

Discovery of 5-Alkyl-2-pyrazol-oxazolidin-4-one Derivatives As Novel Hepatitis B Virus Capsid Assembly Modulators

Synthesis and Anti-Tumor Activity Evaluation of Matijin-Su Derivatives.

Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus.

Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.

Synthesis and Anti-Hepatitis B Virus Activity of Novel Benzimidazole Derivatives

Design and Synthesis of (3-Phenylisoxazol-5-yl)methanimine Derivatives as Hepatitis B Virus Inhibitors

Synthesis and Biological Evaluation of Phenylpropanoid Derivatives

Design and Synthesis of Novel Benzimidazole Derivatives As Inhibitors of Hepatitis B Virus

Synthesis and Antiviral Activity of New Acrylamide Derivatives Containing 1,2,3-Thiadiazole As Inhibitors of Hepatitis B Virus Replication

Synthesis and Anti‐HBV Activities Evaluation of New Ethyl 8‐imidazolylmethyl‐7‐hydroxyquinoline‐3‐carboxylate Derivatives in Vitro

Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives.

Synthesis and Evaluation of 3-Phenylisoxazoline Derivatives As Non-Nucleoside Hepatitis B Virus Inhibitors

Design, Synthesis, Molecular Docking Studies and Anti-Hbv Activity of Phenylpropanoid Derivatives

Discovery and Biological Evaluation of 2-((3-phenylisoxazol-5-yl) Methoxy) Benzamide Derivatives As Potent Nucleocapsid Inhibitors

Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.

Synthesis and in Vitro Anti-Hepatitis B Virus Activity of 6H-[1]Benzothiopyrano[4,3-b]quinolin-9-ols.

Combining Oxymatrine or Matrine with Lamivudine Increased Its Antireplication Effect Against the Hepatitis B Virus in Vitro